There is movement afoot in the US to improve transparency and set limitations on litigation financed by third parties, which has increased drastically in the past decade with costly implications for medical device manufacturers.
In fact, third-party litigation funding (TPLF) is the driving force behind most medical device
The practice at issue, in which funders who are not parties in a lawsuit supply financial support to plaintiffs or law firms in exchange for a portion of the